Licensable university IP
Small molecule CMKLR1 antagonists in inflammatory disease
Small molecule CMKLR1 antagonists in inflammatory disease is marketed for licensing by Stanford University (OTL). It is documented in US patent US 11,730,705. The current assignee of record is US Department of Veterans Affairs. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2041-05-27. Note: the patent's assignee of record is now US Department of Veterans Affairs, not Stanford University (OTL); it appears to have been assigned away, so licensing rights should be confirmed with the current owner.
The patent's current assignee of record is US Department of Veterans Affairs, which differs from the marketing institution (Stanford University (OTL)). Confirm licensing rights with the assignee of record before relying on this listing.
Patent picture
| Field | Value | Reliability | Source |
|---|---|---|---|
| US patent | US 11,730,705 | High | Google Patents |
| Patent title | Small molecule CMKLR1 antagonists in inflammatory disease | High | Google Patents |
| Current assignee | US Department of Veterans Affairs | Good | Google Patents |
| Original assignee | Leland Stanford Junior University | Good | Google Patents |
| Legal status | Active | Moderate | Google Patents |
| Filing date | 2020-04-13 | High | Google Patents |
| Priority date | 2019-05-02 | High | Google Patents |
| Publication date | 2023-08-22 | High | Google Patents |
| Expected expiration | 2041-05-27 | Moderate | Google Patents |
- High 90% and up
- Good 80 to 89%
- Moderate 70 to 79%
Legal status is Google Patents' automated indicator, not a legal determination.
Joined to US 11,730,705 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.
Original listing
This technology is marketed for licensing by Stanford University (OTL). View the original listing.